General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Focus on patient outcomes

Using information technology to improve health

Information technology is already having a significant impact on healthcare innovation and presents vast untapped potential.

Recent research shows that patients now better understand the benefits of technology and are embracing it to improve their health. In recent market research carried out for Novartis, 92 percent of patients and 84 percent of seniors said that they were comfortable using technology. Almost two-thirds of patients also think that technology is helping them to better manage their health.

Novartis defines e-health and m-health as the healthcare system's adoption of the channels and tools of the digital and mobile world: the digitization of healthcare.

E-Health is reshaping the entire healthcare system which exists to deliver interventions such as diagnosis, medicines, care and advice, and technology is impacting every aspect.

Novartis is committed to investing in valuable, innovative technologies and has initiated a number of pilot programs using remote monitoring devices. These devices may someday provide physicians with a wealth of information to proactively manage the health of patients by monitoring adherence to treatment.

In addition, Novartis has developed a number of online communities and mobile apps that help patients better manage their own health.

Novartis expects these new technologies to help it remain successful despite a tougher economic environment, but their development also puts a premium on new capabilities.